BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Research and development spending
3Y CAGR
+6.1%/yr
vs +30.0%/yr prior
5Y CAGR
+7.2%/yr
Consistent
Acceleration
-23.8pp
Decelerating
Percentile
P88
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $477.54M | -5.7% |
| 2024 | $506.46M | +11.1% |
| 2023 | $455.71M | +14.1% |
| 2022 | $399.46M | -11.4% |
| 2021 | $451.02M | +33.8% |
| 2020 | $337.05M | +60.5% |
| 2019 | $209.95M | +49.9% |
| 2018 | $140.07M | +358.4% |
| 2017 | $30.56M | - |